Anavex Life Sciences Corp (AVXL)

[pcguy]

Because investor confidence had already waned on missed trial dates and a little push clouding the waters tipped the remainder. The losses prior to release of trial results was enough to put some investors into a "stop loss" mode, not willing to accept more risk and potentially more loss. Anavex is developing a track record of providing information then going silent, missing targets with no explaination, then issuing options for meeting milestones. Additionally, trial readouts are often not complete or clouded due to, yet again, lack of communication. Finally, Anavex tends to challenge the use of endpoints. This is clever in part, "precision medicine", but has also backfired in areas where they were not completely familiar with the science. The odds are against success, and often, if it walks like a duck, quacks like a duck, and looks like a duck, it's a duck.